钙增强培养基用于黏菌素药敏试验的评估:梯度琼脂扩散法与肉汤微量稀释法
本研究评估了钙增强梯度琼脂扩散法和钙增强肉汤微量稀释法对黏菌素药敏试验的临床适用性,使用来自美国多个医疗中心的217株耐药和敏感患者分离株。与参考肉汤微量稀释法相比,钙增强梯度琼脂扩散法的总体分类一致性和基本一致性分别为73.7%和65.5%,性能因菌群而异,肠杆菌目最高,铜绿假单胞菌最低。即使肠杆菌目,极重大错误率也高达9.2%,钙增强肉汤微量稀释法性能同样不佳,提示这些钙增强方法不适合临床常规黏菌素药敏试验。
要点
- 钙增强梯度琼脂扩散法与参考肉汤微量稀释法分类一致性仅73.7%,基本一致性65.5%。
- 肠杆菌目一致性最高但极重大错误率达9.2%,铜绿假单胞菌一致性最低。
- 钙增强肉汤微量稀释法性能同样不佳,钙增强方法不适合常规黏菌素药敏试验。
核心结论
- 钙增强梯度琼脂扩散法和钙增强肉汤微量稀释法对黏菌素药敏试验错误率不可接受,不适合临床实验室常规使用。
研究设计与样本
- 研究评估钙增强梯度琼脂扩散法和钙增强肉汤微量稀释法,使用来自美国多个医疗中心的217株耐药和敏感患者分离株,与参考肉汤微量稀释法比较。
主要发现
- 钙增强梯度琼脂扩散法总体分类一致性73.7%,基本一致性65.5%。
- 性能因菌群显著不同,肠杆菌目一致性最高,铜绿假单胞菌最低。
- 肠杆菌目极重大错误率9.2%。
- 钙增强肉汤微量稀释法性能同样不佳。
- 钙增强可更准确分类mcr-1耐药分离株,但对敏感和非mcr-1耐药分离株错误率过高。
关键数值与推荐
- 钙增强梯度琼脂扩散法分类一致性73.7%,基本一致性65.5%。
- 肠杆菌目极重大错误率9.2%。
临床怎么用
- 临床实验室不应常规使用钙增强梯度琼脂扩散法或钙增强肉汤微量稀释法进行黏菌素药敏试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite the increasing reliance on polymyxin antibiotics (polymyxin B and colistin) for treatment of multidrug-resistant Gram-negative infections, many clinical laboratories are unable to perform susceptibility testing due to the lack of accurate and reliable methods. Although gradient agar diffusion is commonly performed for other antimicrobials, its use for polymyxins is discouraged due to poor performance characteristics. Performing gradient agar diffusion with calcium enhancement of susceptibility testing media has been shown to improve the identification of polymyxin-resistant isolates with plasmid-mediated resistance (mcr-1). We therefore sought to evaluate the broad clinical applicability of this approach for colistin susceptibility testing by assessing a large and diverse collection of resistant and susceptible patient isolates collected from multiple U.S. medical centers. Among 217 isolates, the overall categorical and essential agreement for calcium-enhanced gradient agar diffusion were 73.7% and 65.5%, respectively, compared to the results for reference broth microdilution. Performance varied significantly by organism group, with agreement being highest for Enterobacterales and lowest for Pseudomonas aeruginosa Nevertheless, even for Enterobacterales, there was a high rate of very major errors (9.2%). Performance was similarly poor for calcium-enhanced broth microdilution. While calcium enhancement did allow for more accurate categorization of mcr-1-resistant isolates, there were unacceptably high rates of errors for both susceptible and non-mcr-1-resistant isolates, raising serious doubts about the suitability of these calcium-enhanced methods for routine colistin susceptibility testing in clinical laboratories.
引用
- Green DA, Macesic N, Uhlemann AC, et al. Evaluation of Calcium-Enhanced Media for Colistin Susceptibility Testing by Gradient Agar Diffusion and Broth Microdilution. J Clin Microbiol. 2020. PMID: 31748324. doi:10.1128/JCM.01522-19
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。